在肺纤维化中,有专业的亲解决媒介的作用吗?
Thomas H Thatcher1, Margaret A T Freeberg1, Yu Par Aung Myo2
1Division of Pulmonary Care and Critical Care Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Pharmacology & therapeutics
|May 27, 2023
概括
专门的亲解决媒介 (SPMs) 通过解决炎症和减少肺痕,在治疗肺纤维化方面表现有前途. 研究表明,肺部疾病的解决途径受损,这表明SPM是潜在的治疗方法.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 肺纤维性疾病涉及纤维细胞增殖和过度的细胞外基质沉积,可能导致呼吸衰竭.
- 炎症解决是通过专门的亲解决媒介 (SPMs) 积极调节的.
- 虽然SPM在炎症性疾病中表现出好处,但它们在肺纤维化中的作用较少被探索.
研究的目的:
- 审查关于间歇性肺部疾病中受损解脱途径的证据.
- 检查SPM在抑制关键纤维化过程中的潜力.
- 讨论SPMs在治疗肺纤维化中的未来治疗影响.
主要方法:
- 对调查SPM和肺纤维化研究的文献综述.
- 对细胞培养和肺纤维化动物模型的分析.
- 对间歇性肺病中解决途径受损的证据的检查.
主要成果:
- 解决途径似乎在间歇性肺病中受损.
- SPM显示出抑制纤维细胞增殖和肌纤维细胞分化的能力.
- 在肺纤维化模型中,SPM可以减少过度的细胞外基质积累.
结论:
- SPM 和相关的脂质调解剂对肺纤维化有治疗潜力.
- 针对SPM的解决途径可以提供一种新的治疗策略.
- 需要进一步的研究来探索SPM在纤维化肺部疾病中的临床应用.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
Drugs Used in Lower Respiratory Disorders: Overview
509
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
509
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
225
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
225
Antiasthma Drugs: Leukotriene Modifiers
379
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
379
Asthma: Pathogenesis and Management
467
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
467
Inflammatory Response
2.2K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.2K


